Form 4: QuidelOrtho CFO Joseph M. Busky Acquires Restricted Stock Units
SEC Form 4 Filing
QuidelOrtho's Chief Financial Officer, Joseph M. Busky, reports the acquisition of 21,367 restricted stock units (RSUs) that will fully vest on June 30, 2025.
Summary
- On February 27, 2024, Joseph M. Busky, the Chief Financial Officer of QuidelOrtho Corp, acquired 21,367 restricted stock units.
- These restricted stock units represent the right to receive one share of QuidelOrtho Corporation common stock each.
- The acquired shares will fully vest on June 30, 2025.
- The reporting was filed on February 29, 2024.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard disclosure of stock units granted to an executive, which is part of their compensation package.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, such as the CFO, and their holdings in the company's stock.
Stakeholder Impact
- The acquisition of restricted stock units by the CFO aligns his interests with those of the shareholders, as the value of the units is tied to the company's stock performance.
Key Dates
| Date | Description |
|---|---|
| 02/27/2024 | Date of transaction: Joseph M. Busky acquired 21,367 restricted stock units. |
| 02/29/2024 | Date of filing: Form 4 filing reporting the transaction. |
| 06/30/2025 | Vesting date: 21,367 shares will fully vest. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.